Developing-country vaccine manufacturers’ technical capabilities can make a difference in global immunization

Members of the Developing Countries Vaccine Manufacturers’ Network (DCVMN) have been actively engaged in the development of COVID-19 vaccine candidates. According to the WHO COVID-19 vaccine landscape updated on 29 December 2020, 18 member manufacturers had vaccines in preclinical or clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayman, Benoit, Dennehy, Maureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330991/
https://www.ncbi.nlm.nih.gov/pubmed/34362602
http://dx.doi.org/10.1016/j.vaccine.2021.07.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330991/
https://www.ncbi.nlm.nih.gov/pubmed/34362602
http://dx.doi.org/10.1016/j.vaccine.2021.07.044

Ejemplares similares